Exploring Sedation Types During Cataract Surgery
Public ClinicalTrials.gov record NCT04725747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Retrospective Study Exploring Midazolam/Ketamine Melt vs IV Sedation in Subjects Undergoing Intraocular Surgery
Study identification
- NCT ID
- NCT04725747
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Vance Thompson Vision
- Other
- Enrollment
- 1,111 participants
Conditions and interventions
Conditions
Interventions
- Intravenous Sedatives with or Without Analgesia Drug
- Midazolam/Ketamine HCl 3mg-50mg sublingual Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 24, 2021
- Primary completion
- May 29, 2021
- Completion
- Jun 29, 2021
- Last update posted
- May 3, 2026
2021
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vance Thompson Vision Clinic | Sioux Falls | South Dakota | 57108 | — |
| Vance Thompson Vision | Sioux Falls | South Dakota | 57108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04725747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04725747 live on ClinicalTrials.gov.